These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24240870)

  • 1. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
    Toba M; Alzoubi A; O'Neill KD; Gairhe S; Matsumoto Y; Oshima K; Abe K; Oka M; McMurtry IF
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H243-50. PubMed ID: 24240870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.
    Abe K; Shinoda M; Tanaka M; Kuwabara Y; Yoshida K; Hirooka Y; McMurtry IF; Oka M; Sunagawa K
    Cardiovasc Res; 2016 Jul; 111(1):16-25. PubMed ID: 27037259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension.
    Tanaka M; Abe K; Oka M; Saku K; Yoshida K; Ishikawa T; McMurtry IF; Sunagawa K; Hoka S; Tsutsui H
    Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29208691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
    Alzoubi A; Almalouf P; Toba M; O'Neill K; Qian X; Francis M; Taylor MS; Alexeyev M; McMurtry IF; Oka M; Stevens T
    Am J Pathol; 2013 Dec; 183(6):1779-1788. PubMed ID: 24113457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
    Liu P; Huang W; Ding Y; Wu J; Liang Z; Huang Z; Xie W; Kong H
    Drug Des Devel Ther; 2021; 15():1653-1666. PubMed ID: 33935492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
    Abe K; Toba M; Alzoubi A; Ito M; Fagan KA; Cool CD; Voelkel NF; McMurtry IF; Oka M
    Circulation; 2010 Jun; 121(25):2747-54. PubMed ID: 20547927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
    Corboz MR; Plaunt AJ; Malinin V; Li Z; Gauani H; Chun D; Cipolla D; Perkins WR; Chapman RW
    Eur J Pharmacol; 2022 Feb; 916():174484. PubMed ID: 34508752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
    Alzoubi A; Toba M; Abe K; O'Neill KD; Rocic P; Fagan KA; McMurtry IF; Oka M
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1708-18. PubMed ID: 23585128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneurysm-type plexiform lesions form in supernumerary arteries in pulmonary arterial hypertension: potential therapeutic implications.
    Oshima K; Crockett ES; Joshi SR; McLendon JM; Matsumoto Y; McMurtry IF; Abe K; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L805-L815. PubMed ID: 31577161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
    Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
    Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.
    Toba M; Alzoubi A; O'Neill K; Abe K; Urakami T; Komatsu M; Alvarez D; Järvinen TA; Mann D; Ruoslahti E; McMurtry IF; Oka M
    Am J Pathol; 2014 Feb; 184(2):369-75. PubMed ID: 24401613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Hypertension.
    Imano H; Kato R; Nomura A; Tamura M; Yamaguchi Y; Ijiri Y; Wu H; Nakano T; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M; Hayashi T
    Biol Pharm Bull; 2021 May; 44(5):669-677. PubMed ID: 33612567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of an animal model of severe pulmonary arterial hypertension.
    Morimatsu Y; Sakashita N; Komohara Y; Ohnishi K; Masuda H; Dahan D; Takeya M; Guibert C; Marthan R
    J Vasc Res; 2012; 49(1):33-42. PubMed ID: 21985792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.